Ambrx Biopharma Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (4)

Latest Posts

About This Stock More About This Stock
Week In Review: Sino Biopharma Acquires F-Star For $161 Million After US Approval
Article By: ChinaBio® Today
Saturday, March 11, 2023 12:59 PM EDT
Sino Biopharma was approved to close its $161 million all-cash acquisition of F-Star. The purchase didn't look like would happen after it was held up for nine months by the US government’s Committee on Foreign Investment in the United States.
In this article: SBMFF Also: AMAM, FSTX
Read
Dow Sheds Over 300 Points After Powell Comments
Article By: Schaeffers Research
Tuesday, March 7, 2023 12:26 PM EDT
Federal Reserve Chair Jerome Powell's latest comments are dragging down sentiment on Wall Street.
In this article: SI, QQQ, SNAP, SPX, VIX, DJI, AMAM
Read
S&P 500 Slips Below Breakeven, Eyeing 5th-Straight Loss
Article By: Schaeffers Research
Thursday, February 23, 2023 12:53 PM EDT
The major indexes are lower midday, with the S&P 500 Index just below breakeven and on track for its fifth-straight daily loss.
In this article: SPX, TDOC, BAND, AMAM
Read
Major Indexes Struggle For Direction After Inflation Report
Article By: Schaeffers Research
Friday, December 9, 2022 12:34 PM EDT
The major indexes are trying to claw back from this morning's fall, prompted by a higher-than-anticipated producer price index (PPI) for November.
In this article: QQQ, SPX, VIX, DJI, BILI, AMAM, PHVS
Read
Week In Review: Insilico Signs Six-Drug Discovery Deal With Sanofi Worth Up To $1.2 Billion
Article By: ChinaBio® Today
Saturday, November 12, 2022 2:40 PM EDT
Insilico Medicine signed a six-drug research collaboration with Sanofi that could be worth up to $1.2 billion. Insilico will receive up to $21.5 million in upfront and target nomination fees for each of the six targets.
In this article: SNY, 600216.SS, MRNA, AMAM, 2142.HK, 2257.HK, EQRX
Read

Latest Tweets for $AMAM

No tweets yet!

PARTNER HEADLINES